EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry. (Articolo in rivista)

Type
Label
  • EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry. (Articolo in rivista) (literal)
Anno
  • 2010-01-01T00:00:00+01:00 (literal)
Alternative label
  • Hindorf C, Glatting G, Chiesa C, Lindén O, Flux G; EANM Dosimetry Committee. (2010)
    EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry.
    in European journal of nuclear medicine and molecular imaging (Print)
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Hindorf C, Glatting G, Chiesa C, Lindén O, Flux G; EANM Dosimetry Committee. (literal)
Pagina inizio
  • 1238 (literal)
Pagina fine
  • 1250 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#altreInformazioni
  • PMID: 20411259 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 37 (literal)
Rivista
Note
  • ISI Web of Science (WOS) (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • 1 - Imagerie Médicale, ONIRIS - Ecole Nationale Vétérinaire, Agroalimentaire et d’Alimentation Nantes Atlantique, Nantes, France; 2 - Klinik für Nuklearmedizin, Universitaet Ulm, Ulm, Germany; 3 - Nuclear Medicine Division, Foundation IRCCS Istituto Nazionale Tumori, Milano, Italy; 4 - Department of Oncology, Lund University Hospital,Lund, Sweden; 5 - Joint Department of Physics, Royal Marsden Hospital & Institute of Cancer Research, London,UK. (literal)
Titolo
  • EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry. (literal)
Abstract
  • INTRODUCTION: The level of administered activity in radionuclide therapy is often limited by haematological toxicity resulting from the absorbed dose delivered to the bone marrow. The purpose of these EANM guidelines is to provide advice to scientists and clinicians on data acquisition and data analysis related to bone-marrow and whole-body dosimetry. MATERIALS AND METHODS: The guidelines are divided into sections \"Data acquisition\" and \"Data analysis\". The Data acquisition section provides advice on the measurements required for accurate dosimetry including blood samples, quantitative imaging and/or whole-body measurements with a single probe. Issues specific to given radiopharmaceuticals are considered. The Data analysis section provides advice on the calculation of absorbed doses to the whole body and the bone marrow. The total absorbed dose to the bone marrow consists of contributions from activity in the bone marrow itself (self-absorbed dose) and the cross-absorbed dose to the bone marrow from activity in bone, larger organs and the remainder of the body. CONCLUSION: As radionuclide therapy enters an era where patient-specific dosimetry is used to guide treatments, accurate bone-marrow and whole-body dosimetry will become an essential element of treatment planning. We hope that these guidelines will provide a basis for the optimization and standardization of the treatment of cancer with radiopharmaceuticals, which will facilitate single- and multi-centre radionuclide therapy studies. (literal)
Prodotto di
Autore CNR
Insieme di parole chiave

Incoming links:


Autore CNR di
Prodotto
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
Insieme di parole chiave di
data.CNR.it